-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Monday's Intraday Session
Share
Listen to the news

Gainers

  • Tango Therapeutics (NASDAQ:TNGX) shares increased by 46.7% to $29.66 during Monday's regular session. The market value of their outstanding shares is at $2.9 billion.
  • Cypherpunk Technologies (NASDAQ:CYPH) shares rose 43.79% to $0.75. The market value of their outstanding shares is at $55.2 million.
  • Incannex Healthcare (NASDAQ:IXHL) shares moved upwards by 23.73% to $3.61. The company's market cap stands at $34.9 million.
  • Precision BioSciences (NASDAQ:DTIL) stock moved upwards by 19.76% to $7.79. The market value of their outstanding shares is at $167.7 million.
  • Talphera (NASDAQ:TLPH) shares increased by 15.52% to $0.9. The market value of their outstanding shares is at $40.2 million.
  • Addex Therapeutics (NASDAQ:ADXN) stock rose 15.35% to $6.76. The market value of their outstanding shares is at $7.2 million.

Losers

  • Bio Green Med Solution (NASDAQ:BGMS) stock decreased by 26.0% to $1.11 during Monday's regular session. The market value of their outstanding shares is at $8.2 million.
  • Inotiv (NASDAQ:NOTV) stock decreased by 25.92% to $0.12. The market value of their outstanding shares is at $5.7 million.
  • Standard BioTools (NASDAQ:LAB) shares decreased by 25.1% to $0.86. The company's market cap stands at $448.9 million.
  • Aditxt (NASDAQ:ADTX) stock declined by 20.29% to $0.05.
  • VolitionRX (AMEX:VNRX) shares fell 20.12% to $1.43. The market value of their outstanding shares is at $14.9 million.
  • Anbio Biotechnology (NASDAQ:NNNN) stock fell 19.97% to $18.4. The market value of their outstanding shares is at $1.0 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending